Chain of Custody

Every vial, traceable
to its source.

We source from cGMP-certified manufacturers, test every batch at an ISO 17025-accredited laboratory, publish every COA without exception, and require physician oversight before any compound reaches a patient. That is the standard. The evidence is below.

01

cGMP Manufacturer

Current Good Manufacturing Practice (cGMP) is a regulatory framework enforced by the FDA that governs facility design, personnel qualifications, equipment calibration, documentation, and batch traceability. A cGMP certificate is not a logo — it requires continuous third-party audits, deviation reporting, and validated synthesis protocols.

We require every manufacturing partner to hold an active cGMP certification, submit to pre-qualification audits before first order, and provide batch manufacturing records with each shipment. Facilities without a current audit status do not receive orders.

Manufacturer selection criteria ↓
02

ISO 17025 Lab Testing

ISO 17025 accreditation is not a supplier certificate — it is an internationally recognized standard for testing laboratory competency. Accredited labs are assessed on method validation, measurement uncertainty, equipment traceability, and staff qualifications. The accreditation body conducts on-site assessments; labs that fail lose accreditation.

Every batch undergoes four mandatory tests before release:

  • Identity — HPLC confirms the compound matches the reference standard by retention time and spectral profile.
  • Purity — HPLC-UV quantifies the active peptide as a percentage of total area, with all impurity peaks recorded.
  • Endotoxin — LAL Kinetic Chromogenic assay detects bacterial endotoxins to <0.1 EU/mg per vial.
  • Sterility — USP <71> incubation for no microbial growth over a 14-day period.

Lab partner: Analytika ISO Labs Inc. (ISO 17025 Accredited — placeholder name pending final contract disclosure)

03

Published COA

A COA is only evidence if it is public. We publish the full Certificate of Analysis for every batch — identity result, purity percentage, molecular mass confirmation, endotoxin level, sterility result, reviewer sign-off, and lab report ID. No COA is held back. No batch ships without one.

You can look up any batch by number without logging in, creating an account, or providing any personal information.

04

Physician Network

No compound ships without physician review. Every patient requesting a protocol completes a consultation with a licensed physician in our network. The physician evaluates the patient's history, current medications, and research goals before authorizing any compound. This is not a checkbox — it is required.

Our physician network spans licensed practitioners across all 50 states. Coordination typically completes within one business day of intake submission.

Request a consultation →
05

You

The point of all of it. You receive a compound with a known identity, a verified purity, a tested sterility, and a physician who has reviewed your protocol. Every step before this one exists so that you can make an informed decision with a qualified medical professional — not a guess.

Manufacturer Selection

What we require before placing a first order

cGMP status alone is not sufficient. Every manufacturing partner must clear each of these gates before we source from them.

Active cGMP Certification

Current, third-party-audited cGMP status. Expired or provisional status disqualifies a facility immediately. We verify directly with the certifying body — not from the manufacturer's claims.

Pre-qualification Audit

Before the first purchase order, we conduct a pre-qualification audit — either on-site or via a third-party auditor. Audit findings are graded; critical findings are a disqualifier with no exceptions.

Validated Synthesis Protocol

Each peptide must have a validated, documented synthesis route. The manufacturer must provide the validation report, including yield data, impurity profiles at each stage, and deviation history.

Batch Manufacturing Records

Every shipment must be accompanied by full batch manufacturing records — raw material certificates, in-process checks, and final release documentation. Records are archived for seven years.

Independent Lab Agreement

The manufacturer must accept that our ISO 17025-accredited laboratory conducts independent retesting of every batch. Manufacturers who refuse independent testing are disqualified.

Annual Re-audit

Qualification is not permanent. We conduct annual re-audits and reserve the right to trigger an unannounced audit following any deviation, complaint, or COA anomaly. A failed re-audit terminates the supplier relationship.

See It Yourself

Three live batches — check them now

These are current batch numbers with their COA data inline. Click "Verify" to pull up the full Certificate of Analysis — same result you'd get entering the batch number on /verify.

BPC-157 Recovery & Repair
Batch SPC-BPC157-2410-A
Tested by Analytika ISO Labs Inc. (ISO 17025 Accredited)
Lab report ALI-2024-0847-BPC
Reviewer Dr. M. Stanton, PharmD — QA Lead (Placeholder)
Identity Confirmed
Purity 99.2%
Molecular Mass 1419.5 Da (expected 1419.5)

+ 3 more tests — all passed

View Full COA →
Semaglutide Metabolic & Body Composition
Batch SPC-SEMA-2411-A
Tested by Analytika ISO Labs Inc. (ISO 17025 Accredited)
Lab report ALI-2024-0922-SEM
Reviewer Dr. M. Stanton, PharmD — QA Lead (Placeholder)
Identity Confirmed
Purity 99.4%
Molecular Mass 4113.6 Da (expected 4113.6)

+ 3 more tests — all passed

View Full COA →
Epitalon Longevity & Aging
Batch SPC-EPIT-2412-A
Tested by Analytika ISO Labs Inc. (ISO 17025 Accredited)
Lab report ALI-2024-0974-EPI
Reviewer Dr. M. Stanton, PharmD — QA Lead (Placeholder)
Identity Confirmed
Purity 99.8%
Molecular Mass 390.4 Da (expected 390.4)

+ 3 more tests — all passed

View Full COA →
Our Limits

What we won't do

This is not a grey-market operation with a professional website. These are structural limits — not policies that get waived for the right customer.

Sell as research chemicals

We do not sell peptides labeled "for research use only" as a workaround to avoid physician oversight. Every compound in our catalog requires a physician consultation before it reaches a patient. There are no exceptions, no back-channel orders, and no "self-research" pathway.

Ship without physician review

No compound ships before a licensed physician has reviewed the patient's intake, history, and protocol. Not for existing customers. Not for repeat orders. Not for compounds with low risk profiles. Physician review is a hard gate on every transaction.

Publish COAs selectively

We do not publish only the batches that passed or withhold COAs from products with lower-than-average purity numbers. Every batch has a COA. Every COA is public. A result of 98.7% purity is published exactly the same way as 99.8%. Batch transparency means all batches, always.

Accept unaudited suppliers

We do not source from manufacturers who decline pre-qualification audits, cannot provide batch manufacturing records, or hold expired cGMP status. Lower price from an unaudited source is not a trade-off we make. The sourcing criteria above are not negotiable.